2-((BENZYLOXY)METHYL)PROPANE-1,3-DIOL, 95.0%, 250mg

(4-bromo-3,5-dimethyl-1H-pyrazol-1-yl)acetonitrile, 95.0%, 5g

6-t-Butyl-4-chlorothieno[3,2-d]pyrimidine, 95.0%, 10g

(+/-)-Hydrobenzoin>98.0%(GC)5g

(4-Bromo-3,5-dimethyl-pyrazol-1-yl)-acetic acid, 95.0%, 1g

Ethyl 6-fluoro-4-hydroxyquinoline-3-carboxylate, 95.0%, 25g

tBuXPhos Pd G3, >98.0%, 25g

2-(2-oxo-2-phenylethyl)-1H-isoindole-1,3(2H)-dione, 97%, 1g

4,5,6,7-Tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid, 97%, 100mg

1-Tetradecyne>95.0%(GC)5mL

1-(4,5-Dimethoxy-2-nitro-phenyl)-ethanone, 95.0%, 5g

2-(Hydroxymethyl)propane-1,3-diol>98.0%(GC)5g

Dialysis membrane Spectra/Por® Biotech CE MWCO 50,000, 10 mm, 1 Piece(s)